Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at nivolumab, relatlimab and chemotherapy for non small cell lung cancer (RELATIVITY1093)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers

Status:

Open

Phase:

Phase 3

Details

This trial is looking at nivolumab, relatlimab and chemotherapy for non small cell lung cancer that has spread or come back. It is comparing this to pembrolizumab and chemotherapy.

It is for people who:

  • are having their first treatment for non small cell lung cancer that has spread to another part of the body or has come back

  • have a type of non small cell lung cancer called non squamous cell

  • have cancer cells with a small amount of the PD-L1 protein on their surface

Recruitment start: 6 March 2025

Recruitment end: 31 July 2027

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Adam Januszewski

Supported by

Bristol-Myers Squibb

Last reviewed: 13 Mar 2026

CRUK internal database number: 20145

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Connect with other people affected by cancer and share your experiences.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.